Jeremy Parfitt
Overview
Explore the profile of Jeremy Parfitt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
659
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chretien M, Bailey D, Asher L, Parfitt J, Driman D, Gregor J, et al.
BMJ Open
. 2023 Feb;
13(2):e057151.
PMID: 36828648
Objective: The non-metabolised antihistamine fexofenadine has oral absorption resulting from transporter activity. Uptake by enterocyte organic anion transporting polypeptides and efflux by an ATP-binding cassette transporter (P-glycoprotein) are primary determinants....
2.
Aziz S, Sey M, Marotta P, Driman D, Parfitt J, Teriaky A, et al.
Transplant Proc
. 2021 Jul;
53(6):1975-1979.
PMID: 34272052
Background: Recurrence of hepatocellular carcinoma (HCC) after liver transplantation is a major cause of morbidity and mortality. To date, there is no widely accepted pathologic assessment tool to predict HCC...
3.
Kurdi M, Alghamdi B, Parfitt J, Ang L
Folia Neuropathol
. 2021 May;
59(1):98-103.
PMID: 33969681
Several studies have recently described 4-repeat tauopathies that are characterized by the presence of globular glial inclusions. These inclusions are astrocytic or oligodendroglial, show extensive white matter involvement, and have...
4.
Chretien M, Bailey D, Asher L, Parfitt J, Driman D, Gregor J, et al.
BMJ Open
. 2020 Mar;
10(3):e034086.
PMID: 32139488
Objective: Severity of coeliac disease depends in part on the extent of small intestinal mucosa injury. Patients with the most abnormal pathology have loss of duodenal villi CYP3A4, a drug-metabolising...
5.
Koichopolos J, Keow J, Parfitt J, Yoshy C, Wiseman D, Leslie K
Int J Surg Case Rep
. 2019 Dec;
66:53-57.
PMID: 31812122
Introduction: Duodenal necrosis is a rare complication of acute pancreatitis but can occur given the shared blood supply to the head of the pancreas and the duodenum. Presentation Of Case:...
6.
Cecchini M, Walsh J, Parfitt J, Chakrabarti S, Correa R, MacKenzie M, et al.
Hum Pathol
. 2019 May;
90:70-79.
PMID: 31121192
The treatment for colorectal cancer is largely surgical followed by adjuvant chemotherapy in high-risk cases. In patients with stage II cancer, there is no clear benefit for chemotherapy, and the...
7.
Anantha R, Shaler C, Meilleur C, Parfitt J, Haeryfar S, Hernandez-Alejandro R
Front Med (Lausanne)
. 2016 Aug;
3:32.
PMID: 27556025
Background And Aims: A short-interval, two-stage approach termed associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) increases the number of patients with extensive malignant disease of the...
8.
Linehan W, Spellman P, Ricketts C, Creighton C, Fei S, Davis C, et al.
N Engl J Med
. 2015 Nov;
374(2):135-45.
PMID: 26536169
Background: Papillary renal-cell carcinoma, which accounts for 15 to 20% of renal-cell carcinomas, is a heterogeneous disease that consists of various types of renal cancer, including tumors with indolent, multifocal...
9.
Sy K, Parfitt J, Marginean C, Riddell R, Streutker C
Histopathology
. 2014 Nov;
66(7):1003-9.
PMID: 25393329
Aims: Inflammatory oesophageal pseudotumours are rare lesions, thought to be reactive. Due to marked atypia of the stromal cells, these can be misdiagnosed as malignancies. The objective of this study...
10.
Osmond A, Li-Chang H, Kirsch R, Divaris D, Falck V, Liu D, et al.
J Clin Pathol
. 2014 Jul;
67(9):781-6.
PMID: 25004943
Aims: Following the introduction of colorectal cancer screening programmes throughout Canada, it became necessary to standardise the diagnosis of colorectal adenomas. Canadian guidelines for standardised reporting of adenomas were developed...